GRIDX to Tulsa Welcome Happy Hour

GRIDX to Tulsa Welcome Happy Hour:

Join us to welcome a select group of GRIDX founders to Tulsa on November 6th at Fulton Street Books & Cafe for a Happy Hour from 5pm - 7pm. Each of the founders will introduce themselves briefly starting at 5:30pm.

This is an opportunity to connect with our cohort of 11 biotech/deep tech startups tackling global challenges in energy, climate, health, agriculture, and food who are spending the next month exploring Tulsa as a potential US home base.

As we all know, one of Tulsa's strengths is the people and that's you! Our hope is our visitors will get to know you and you will get to know them, and this happy hour will serve as the beginning of ongoing and meaningful relationships.

Meet the Fall 2024 Cohort:

1. AQUIT is a biotech startup that has developed cost-effective treatments to activate and modulate natural immunity in farmed fish by identifying and reproducing a key salmon protein, replacing antibiotics, enhancing survival rates, and boosting immunity, with plans to expand its AI-driven technology to species like tilapia, shrimp, poultry, other farm animals, and pets.
2. ArgenTag has developed a high-resolution platform that democratizes access to single-cell sequencing by significantly reducing costs, enabling researchers to analyze genetic material at the individual cell level and gain unprecedented insights into cellular diversity, development, and disease progression that are often missed in bulk sequencing.
3. Dogma Biotech accelerates drug development by leveraging genetic minimalism—reducing an organism's genome to essential survival genes—and glycosylation, the process of adding sugar molecules to proteins or lipids, enabling the creation of drugs five times faster and cheaper while doubling safety and efficacy.
4. Einsted uses plasma pyrolysis to break down methane into clean hydrogen and solid carbon, avoiding CO2 emissions and eliminating the need for capture and storage, with the solid carbon being applicable in industries like construction, pigments, automotive, and fertilizer to promote greener, more sustainable production.
5. Food4You is a biotech platform specializing in advanced fermentation techniques to create plant-based starter cultures that enhance the flavor, texture, and performance of food products, offering clean-label solutions through fermentation optimization and bacteria genomics for industries looking to expand their offerings without compromising taste or nutrition.
6. Michroma uses precision fermentation to create natural colorants, flavors, and fragrances. Their goal is to replace artificial additives in food products with healthier, more sustainable alternatives.
7. Fungi life develops sustainable, biodegradable, and non-toxic biosurfactants using fungal biotechnology, produced through a circular process that upcycles starch-rich agro-industrial waste, with applications ranging from oil wastewater restoration to crude-oil mobilization.
8. Nunatak Biotech develops biologicals—products made from living organisms used in medical treatments and diagnostics—for sustainable agriculture, formulating them with microorganisms from extreme environments to help crops thrive under adverse conditions, reduce chemical inputs, and improve stress tolerance.
9. Qnity uses quantum electrochemistry to screen compound libraries for target binding affinity and ADMETox (Absorption, Distribution, Metabolism, Excretion, and Toxicity), providing pharmaceutical and biotech companies with tools like an affinity sensor platform and library preparation equipment to evaluate large compound libraries and select the best drug candidates for preclinical and clinical testing.
10. Qumir Nano produces bio-nanosolutions—nanoscale systems designed for biological or medical applications—for agriculture, offering non-toxic alternatives to chemical solutions through products like bio-nano fungicides and bio-nanofertilizers made with unique microorganisms.
11. Spherebio is developing personalized cancer vaccines using engineered nanoparticles to deliver tumor antigens directly to immune cells, triggering a targeted immune response to provide more precise and effective treatments for aggressive and treatment-resistant cancers.

Host or Publisher Atento Capital